Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 77.39%482.16K | 58.52%467.24K | 18.47%400.32K | -51.99%545.91K | -198.89%-358.55K | 11.23%271.81K | 2.57%294.75K | 33.68%337.9K | -14.56%1.14M | -88.58%362.59K |
| Selling and administrative expenses | 80.36%468.5K | 56.57%439.69K | 18.26%395.56K | -10.53%1.07M | -56.19%198.55K | 11.76%259.75K | 0.69%280.82K | 36.25%334.47K | -5.82%1.2M | 59.02%453.17K |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | --11.13K | --77.62K | ---- | ---- | ---- |
| -General and administrative expense | 80.36%468.5K | 56.57%439.69K | 18.26%395.56K | -10.53%1.07M | -56.19%198.55K | 11.76%259.75K | 0.69%280.82K | 36.25%334.47K | -5.82%1.2M | 59.02%453.17K |
| Other operating expenses | 13.32%13.67K | 97.77%27.55K | 39.22%4.76K | -739.26%-527.68K | -514.98%-557.1K | 0.86%12.06K | 64.27%13.93K | -52.96%3.42K | -210.85%-62.88K | -103.14%-90.59K |
| Operating profit | -77.39%-482.16K | -58.52%-467.24K | -18.47%-400.32K | 51.99%-545.91K | 198.89%358.55K | -11.23%-271.81K | -2.57%-294.75K | -33.68%-337.9K | 14.56%-1.14M | 88.58%-362.59K |
| Net non-operating interest income (expenses) | -22.67%107.06K | -4.99%130K | 0 | 0 | 0 | 1,487.94%138.45K | 1,049.14%136.82K | 24.47%-29.03K | 99.99%-1 | |
| Non-operating interest income | ---- | -22.67%107.06K | -4.99%130K | ---- | ---- | ---- | --138.45K | --136.82K | ---- | ---- |
| Non-operating interest expense | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | -24.47%29.03K | -99.99%1 |
| Other net income (expenses) | 101.38%34.4K | 55,924.00%27.91K | 167,387.00%463.94K | 99.18%-40.69K | 165.80%2.18M | -49.61%-2.49M | 98.68%-50 | 643.14%277 | -120.61%-4.98M | -118.38%-3.31M |
| Gain on sale of security | -109,624.66%-80.1K | 55,924.00%27.91K | -63,433.94%-175.44K | 97.74%-40.69K | 69.41%-40.85K | 100.00%-73 | 98.68%-50 | 643.14%277 | -4,466.05%-1.8M | -251.90%-133.54K |
| Special income (charges) | --0 | --0 | --639.37K | --0 | 182.44%2.64M | ---2.64M | --0 | --0 | -40.17%-3.2M | -117.47%-3.2M |
| -Less:Impairment of capital assets | --0 | ---- | ---- | --0 | -182.44%-2.64M | --2.64M | ---- | ---- | 117.47%3.2M | --3.2M |
| -Less:Other special charges | ---- | ---- | ---562.54K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | --76.83K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non-operating income (expenses) | -21.81%114.5K | ---- | ---- | ---- | ---- | --146.45K | ---- | ---- | -59.58%27.06K | ---- |
| Income before tax | 83.80%-447.76K | -112.51%-332.28K | 196.42%193.61K | 90.45%-586.6K | 169.07%2.53M | -44.35%-2.76M | 48.08%-156.35K | 24.86%-200.8K | -69.45%-6.14M | 21.99%-3.67M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 84.51%-447.76K | 58.16%-332.28K | 125.54%88.23K | 44.55%-3.37M | 118.18%656.53K | -50.98%-2.89M | -163.76%-794.24K | -29.28%-345.46K | -67.85%-6.09M | 23.22%-3.61M |
| Net income continuous operations | 83.80%-447.76K | -112.51%-332.28K | 196.42%193.61K | 90.45%-586.6K | 169.07%2.53M | -44.35%-2.76M | 48.08%-156.35K | 24.86%-200.8K | -69.45%-6.14M | 21.99%-3.67M |
| Net income discontinuous operations | --0 | --0 | 27.15%-105.39K | -4,907.42%-2.79M | ---1.88M | ---127.01K | ---637.89K | ---144.66K | --57.99K | ---- |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 84.51%-447.76K | 58.16%-332.28K | 125.54%88.23K | 44.55%-3.37M | 118.23%656.53K | -50.98%-2.89M | -163.76%-794.24K | -29.28%-345.46K | -67.85%-6.09M | 23.44%-3.6M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 84.51%-447.76K | 58.16%-332.28K | 125.54%88.23K | 44.55%-3.37M | 118.23%656.53K | -50.98%-2.89M | -163.76%-794.24K | -29.28%-345.46K | -67.85%-6.09M | 23.44%-3.6M |
| Diluted earnings per share | 0 | 0 | 0 | 133.33%0.01 | 200.00%0.02 | 0.00%-0.01 | 0 | 0 | -50.00%-0.03 | 33.33%-0.02 |
| Basic earnings per share | 0 | 0 | 0 | 133.33%0.01 | 200.00%0.02 | 0.00%-0.01 | 0 | 0 | -50.00%-0.03 | 33.33%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.